An updated patent review of antitumor macrocyclic kinase inhibitors (2019 present)
{{output}}
Introduction: Small molecule kinase inhibitors are crucial in the treatment of tumors, and the development of novel inhibitors is a primary approach to combat the continuous emergence of drug resistance. Macrocyclization has emer... ...
